| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.13▼ | 4.12▼ | 4.11▲ | 4.05▲ | 4.42▼ |
| MA10 | 4.12▼ | 4.12▼ | 4.11▼ | 4.04▲ | 4.24▼ |
| MA20 | 4.11▼ | 4.11▲ | 4.08▲ | 4.36▼ | 5.18▼ |
| MA50 | 4.12▼ | 4.07▲ | 4.01▲ | 4.26▼ | 7.70▼ |
| MA100 | 4.12▼ | 4.03▲ | 4.14▼ | 5.60▼ | 7.13▼ |
| MA200 | 4.09▲ | 4.21▼ | 4.53▼ | 7.54▼ | 7.92▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | -0.004▼ | 0.002▲ | -0.025▼ | 0.074▲ |
| RSI | 45.732▼ | 52.195▲ | 54.223▲ | 44.831▼ | 37.675▼ |
| STOCH | 73.810 | 46.970 | 56.218 | 34.367 | 56.820 |
| WILL %R | -60.000 | -63.636 | -38.889 | -61.579 | -52.854 |
| CCI | 3.692 | -28.801 | 48.956 | -1.283 | -13.515 |
|
Wednesday, February 18, 2026 03:13 PM
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...
|
|
Monday, February 09, 2026 04:26 PM
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
|
|
Monday, February 09, 2026 07:30 AM
Anavex Life Sciences (NASDAQ:AVXL) executives used the company’s fiscal 2026 first-quarter earnings call to outline regulatory next steps for oral blarcamesine in early Alzheimer’s disease and to revi ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 20/02/26 | 4.17 | 4.18 | 4.07 | 4.11 | 716,693 |
| 19/02/26 | 4.13 | 4.14 | 4.00 | 4.12 | 729,024 |
| 18/02/26 | 4.03 | 4.155 | 4.00 | 4.04 | 932,687 |
| 17/02/26 | 3.97 | 4.0861 | 3.89 | 4.04 | 886,446 |
| 13/02/26 | 3.96 | 4.18 | 3.91 | 3.93 | 1,069,716 |
| 12/02/26 | 3.90 | 4.00 | 3.775 | 3.92 | 1,338,000 |
| 11/02/26 | 3.97 | 4.04 | 3.745 | 3.88 | 1,406,226 |
| 10/02/26 | 4.34 | 4.35 | 3.95 | 3.96 | 1,669,436 |
| 09/02/26 | 4.20 | 4.54 | 4.07 | 4.35 | 1,800,200 |
| 06/02/26 | 4.06 | 4.26 | 3.82 | 4.10 | 1,672,897 |
|
|
||||
|
|
||||
|
|